Efficacy of Pirfenidone as Antifibrotic Agent in Patients with Post Covid Fibrosis

Histological Evaluation of The Possible Therapeutic Effect of Pirfenidone on Bleomycin-Induced Pulmonary Fibrosis in Adult Male Albino Rats

Effect of Chest Physiotherapy on patient Hospitalized With Interstitial pulmonary fibrosis in intensive care unit

EVALUATION OF HEALTH RELATED – QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AT ZAGAZIG UNIVERSITY HOSPITALS

THE EFFECT OF SELENIUM SUPPLEMENTATION ON LUNG FUNCTIONS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

BRONCHIAL ASTHMA AND COPD: IMPACT OF PHARMACEUTICAL CARE ON OUTCOMES AND QUALITY OF LIFE IN EGYPTIAN PATIENTS

Possible Protective Role of Pirfenidone Versus Combined Antifibrotic Therapy Colchicine and Pirfenidone in a Rat Model of Bleomycin Induced Pulmonary Fibrosis and Evaluation of t

ACUTE PULMONARY EMBOLISM: PATIENT CHARACTERISTIC AND MANAGEMENT STRATEGY IN AN EGYPTIAN COHORT OF PATIENTS

REGISTRY OF PATIENTS WITH PULMONARY HYPERTENSION PRESENTED TO AIN-SHAMS UNIVERSITY HOSPITALS

OCCUPATIONAL AND ENVIRONMENTAL RISK FACTORS OF IDIOPATHIC PULMONARY FIBROSIS IN EGYPT